ALSA Holdings
Overview
ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics. With a strong operations background in drug development, our team seeks to bring together outstanding entrepreneurs and world class academic researchers to help bring promising new treatments to market. We invest across a wide spectrum of therapeutic areas, targeting high unmet need with impactful outcomes for patients and society at large.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Epsilogen | Sep 2024 | Series B Extension | Co-investor |
Key People
Bruce Goldsmith
Operating Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is ALSA Holdings based?
ALSA Holdings is headquartered in London, England, United Kingdom.
When was ALSA Holdings founded?
ALSA Holdings was founded in 2019.
How many portfolio companies does ALSA Holdings have?
ALSA Holdings has 1 portfolio company in Caplight's dataset.
What are some companies in ALSA Holdings's portfolio?
Portfolio companies visible on Caplight include Epsilogen.
What was ALSA Holdings's most recent investment shown here?
ALSA Holdings's most recent investment in this portfolio sample was in Epsilogen in 2024.
What sectors does ALSA Holdings focus on?
ALSA Holdings focuses on Healthcare & Life Sciences.
What company stages does ALSA Holdings focus on?
ALSA Holdings typically invests at the Early stage.
What is ALSA Holdings's AUM?
ALSA Holdings's assets under management are estimated between $50.0M and $100.0M.